Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Durechova K"'
Recent evidence suggests that complex karyotype (CK) defined by the presence of ≥3 chromosomal aberrations (structural and/or numerical) identified by using chromosomebanding analysis (CBA) may be relevant for treatment decision-making in chronic l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::55338e323279f41cfc8c60ef4964e431
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000561
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000561
Autor:
Baliakas, P, Jeromin, S, Iskas, M, Puiggros, A, Plevova, K, Nguyen-Khac, F, Davis, Z, Rigolin, GM, Visentin, A, Xochelli, A, Delgado, J, Baran-Marszak, F, Stalika, E, Abrisqueta, P, Durechova, K, Papaioannou, G, Eclache, V, Dimou, M, Iliakis, T, Collado, R, Doubek, M, Calasanz, MJ, Ruiz-Xiville, N, Moreno, C, Jarosova, M, Leeksma, AC, Panayiotidis, P, Podgornik, H, Cymbalista, F, Anagnostopoulos, A, Trentin, L, Stavroyianni, N, Davi, F, Ghia, P, Kater, AP, Cuneo, A, Pospisilova, S, Espinet, B, Athanasiadou, A, Oscier, D, Haferlach, C, Stamatopoulos, K, ERIC European Res Initiative CLL
Publikováno v:
BLOOD
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Recent evidence suggests that complex karyotype (CK) defined by the presence of >= 3 chromosomal aberrations (structural and/or numerical) identified by using chromosome-banding analysis (CBA) may be relevant for treatment decision-making in chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9f9f689ecd14b481ee08ad2c93add567
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2924
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Plevova, K., Malcikova, J., Sarka Pavlova, Kotaskova, J., Poppova, L., Smardova, J., Diviskova, E., Durechova, K., Oltova, A., Brychtova, Y., Panovska, A., Doubek, M., Pospisilova, S.
Publikováno v:
Web of Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7d08830811fa30665c54c22f1ae7f115
https://publons.com/wos-op/publon/3591180/
https://publons.com/wos-op/publon/3591180/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Blanca Espinet, M. Jose Calasanz, Marie Jarošová, Carolina Moreno, Julio Delgado, Andrea Visentin, Niki Stavroyianni, Rosa Collado, Florence Cymbalista, Helena Podgornik, Kostas Stamatopoulos, Zadie Davis, Michael Doubek, Claudia Haferlach, Fred Davi, Achilles Anagnostopoulos, Arnon P. Kater, Šárka Pospíšilová, Panayiotis Panayiotidis, Sabine Jeromin, David Oscier, Florence Nguyen-Khac, Maria Dimou, Neus Ruiz-Xivillé, Antonio Cuneo, Anna Puiggros, Panagiotis Baliakas, Theodoros Iliakis, Aliki Xochelli, Anastasia Athanasiadou, Alexander C. Leeksma, Paolo Ghia, Pau Abrisqueta, Karla Plevová, Virginie Eclache, George Papaioannou, Livio Trentin, Gian Matteo Rigolin, Michalis Iskas, Kristina Durechova, Evangelia Stalika, Fanny Baran-Marszak
Publikováno v:
Blood
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Blood, 133(11), 1205-1216. American Society of Hematology
Blood, 2019, 133 (11), pp.1205-1216. ⟨10.1182/blood-2018-09-873083⟩
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Blood, 133(11), 1205-1216. American Society of Hematology
Blood, 2019, 133 (11), pp.1205-1216. ⟨10.1182/blood-2018-09-873083⟩
Recent evidence suggests that complex karyotype (CK) defined by the presence of =3 chromosomal aberrations (structural and/or numerical) identified by chromosome banding analysis (CBA) may be relevant for treatment decision-making in chronic lymphocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8b1e871dd0e81c73cb3464994593cc
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1389
https://fundanet.fihgu.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1389
Autor:
Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Jeromin S; MLL Munich Leukemia Laboratory, Munich, Germany., Iskas M; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Puiggros A; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Plevova K; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Nguyen-Khac F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Rigolin GM; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Visentin A; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Xochelli A; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Delgado J; Department of Hematology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain., Baran-Marszak F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Stalika E; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Abrisqueta P; Servei d'Hematología, Hospital Vall d'Hebron, Barcelona, Spain., Durechova K; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Papaioannou G; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Eclache V; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Dimou M; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Iliakis T; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Collado R; Servicio de Hematología, Consorcio Hospital General Universitario, Valencia, Spain., Doubek M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Calasanz MJ; Servicio de Genética Citogenética, Departamento de Genética, Universidad de Navarra, Pamplona, Spain., Ruiz-Xiville N; Servei Laboratori Hematologia, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Moreno C; Servei d'Hematologia, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain., Jarosova M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Leeksma AC; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Panayiotidis P; Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece., Podgornik H; Department of Hematology, University Medical Centre Ljubljana, Ljubljana, Slovenia; and., Cymbalista F; Laboratoire d'hématologie, Hopital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France., Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Trentin L; Hematology Division, Department of Medicine, University of Padua, Padua, Italy., Stavroyianni N; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Davi F; Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France., Ghia P; Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands., Cuneo A; Hematology Section, St. Anna University Hospital, Ferrara, Italy., Pospisilova S; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Espinet B; Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain.; Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain., Athanasiadou A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Stamatopoulos K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
Publikováno v:
Blood [Blood] 2019 Mar 14; Vol. 133 (11), pp. 1205-1216. Date of Electronic Publication: 2019 Jan 02.